An acquirer is looking to buy/acquire major stake in a profitable company in the healthcare, ITES and Telecom VAS segment.
The company should be service oriented company with asset light business model with turnover of up to Rs. 40 Cr.
The company/business should have successfully crossed the proof of concept stage and should have steady revenue stream.
It should be profitable business with a robust business pipeline, primarily targeting mass market (not to any niche market segment).
The present management should be available to stay on at the choice of the buyer. However, the management control would invariably have to be with the buyer. They would look to acquire minimum 51% stake. While a majority stake/outright purchase is the preferred route, the client is open to considering JVs and buying minority stake as well (but with Affirmative rights).
Scalability of operations with the support of the buyer is an important criterion.
Preferably, it should be headquartered in North India/NCR
To shore up more Foreign Investments, the government liberalized FDI limits in dozen sectors to boost the sagging economy. Stock markets reacted positively after the government relaxed FDI norms in several sectors.
Deutsche Securities Mauritius Limited has sold its 1.95 percent stake in Jubilant Life Sciences Limited, a global life sciences and pharmaceutical company, for just over INR122 crore. The sale of the stake was performed as an open market transaction, and purchased by Citigroup Global Markets Mauritius Pvt. Ltd.